Identify the Key Factors Influencing the Wound Treatments Market in the UK.
Our Wound Treatments in the UK report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (1999-2004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.
Product coverage: sticking plasters, other wound treatments
Data coverage: market sizes (historic and forecasts), company shares and brand shares
Why buy this report?
--Get a detailed picture of the wound treatments industry
--Identify growth sectors and factors driving change
--Understand the competitive environment, the market's major players and leading brands
--Use five-year forecasts to assess how the market is predicted to develop
With a network of over 600 analysts worldwide, we have a unique capability to develop reliable information resources to help drive informed strategic planning.
Topics Covered: 1. EXECUTIVE SUMMARY 2. OPERATING ENVIRONMENT - 2.1 OTC Registration and Classification - 2.2 Vitamins & Dietary Supplements Registration and Classification - 2.3 Advertising - 2.4 Packaging and Labelling - 2.5 Distribution - 2.6 De-listing or De-reimbursement - 2.7 Traditional Remedies - 2.8 Homeopathy - 2.9 Generics - 2.10 Consumer Expenditure on Health Goods and Medical Services - 2.11 Life Expectancy 3. OTC HEALTHCARE SALES - 3.1 Market Performance - 3.2 Switches - 3.3 Key Trends and Developments - 3.4 Competitive Environment - 3.5 Leading Company Profiles - Bayer Plc - 3.6 Leading Company Profiles - Boots Healthcare International - 3.7 Leading Company Profiles - GlaxoSmithKline Plc - 3.8 Leading Company Profiles - Johnson & Johnson MSD Ltd - 3.9 Leading Company Profiles - Novartis Pharmaceuticals UK Ltd - 3.10 Leading Company Profiles - Pfizer Consumer Healthcare Ltd - 3.11 Leading Company Profiles - Reckitt Benckiser Plc - 3.12 Leading Company Profiles - Roche Products Ltd - 3.13 Leading Company Profiles - Seven Seas Ltd - 3.14 Leading Company Profiles - SSL International Plc - 3.15 Leading Company Profiles - Wyeth Consumer Healthcare - 3.16 Emerging and Niche Companies - 3.17 Retail Distribution - 3.18 Retailer Activity and Private Label Trends - 3.19 Forecast Market Performance 4. WOUND TREATMENTS SALES - 4.1 Sector Performance - 4.2 New Product Developments 5. OTHER OTC 6. DEFINITIONS
The OTC healthcare market is characterised by a distinct shift towards consolidation. By far the most significant development was the acquisition by Bayer Consumer Care of Roche Consumer Health, finalised in July 2005. Combining the two businesses will enable Bayer to tap significant synergies and supplement its product range with internationally known brands such as Rennie (digestive remedies) and Feminax (analgesics).
In October 2005, Boots Group Plc announced its intention to sell Boots Healthcare International, its consumer health business, to Reckitt Benckiser, in line with its strategic focus on its retail pharmacy business. The divesture will clear the way for Boots's proposed merger with Alliance Unichem Plc, the third largest pharmacy network in Europe.
Companies Mentioned Include:
- GlaxoSmithKline Plc - Crookes Healthcare Ltd - Reckitt Benckiser Plc - Pfizer Consumer Healthcare Ltd - Seven Seas Ltd - SSL International Plc - Wyeth Consumer Healthcare Inc - Boots Co Plc, The - Roche Products Ltd - Ernest Jackson Ltd - Bayer Plc - Novartis Pharmaceuticals UK Ltd - Holland & Barrett Retail Ltd - Masterfoods UK Ltd - Johnson & Johnson Ltd - DDD Group, The - Pharmacia & Upjohn Cambridge Ltd - GlaxoSmithKline UK Ltd - Schering Healthcare Ltd - Chemist Brokers Ltd - Chefaro Proprietaries Ltd - Mentholatum Co Ltd, The - Beiersdorf UK Ltd - Schering-Plough Ltd - Omega Pharma SA - Boehringer Ingelheim Ltd - Healthspan Group Ltd - Goldshield Healthcare Direct Ltd - Procter & Gamble Ltd - Tosara Products UK Ltd - UCB Pharma - Ransom Consumer Healthcare - Stiefel Laboratories (UK) Ltd - Vitabiotics Ltd - Thornton & Ross Ltd - Healthy Direct Ltd - Lane Health Products Ltd, GR - Lichtwer Pharma UK Ltd - De Witt & Co Ltd, E C - Rhone-Poulenc Rorer - Sankyo Pharma UK Ltd - Colgate-Palmolive UK Ltd - Merck Sharp & Dohme Ltd - L'Oreal (UK) Ltd - Merck Consumer Healthcare Ltd - Lofthouse of Fleetwood Ltd - Pharmadass Ltd - Solgar Vitamins & Herbs Ltd - Combe International Ltd - Whitehall Laboratories Ltd - Mars UK Ltd - Adams Confectionery - Peter Black Healthcare Ltd - English Grains Ltd - Health Perception Co Ltd
For more information visit http://www.researchandmarkets.com/reports/c38177
|Printer friendly Cite/link Email Feedback|
|Article Type:||Industry overview|
|Date:||Jun 13, 2006|
|Previous Article:||BridgeCo Raises $23M in Latest Venture Finance Round; Silicon and Middleware Provider for Networked Consumer Electronics Opens Los Angeles Business...|
|Next Article:||Integrian Wins Contract for Victorian Department of Transportation Event Recording Solutions.|